BRIEF-Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business

Reuters2023-11-29

Nov 28 (Reuters) - Timber Pharmaceuticals Inc :

* TIMBER PHARMACEUTICALS RECEIVES COURT APPROVAL OF ALL “FIRST DAY” MOTIONS TO SUPPORT BUSINESS OPERATIONS & DISCLOSES COMMUNICATION FROM NYSE AMERICAN

* TIMBER PHARMACEUTICALS INC- HAS RECEIVED $3.0 MILLION OF NEW MONEY DIP FUNDING

* TIMBER PHARMACEUTICALS INC- DIP FINANCING IS BEING PROVIDED BY LEO US HOLDING, INC., AS LENDER

* TIMBER PHARMACEUTICALS: RECEIVED AUTHORIZATION TO CONTINUE TO PAY VENDORS IN ORDINARY COURSE FOR GOODS AND SERVICES PROVIDED ON A POST-PETITION BASIS

* TIMBER PHARMACEUTICALS INC: RECEIVED AUTHORIZATION TO CONTINUE TO PAY EMPLOYEE WAGES, PROVIDE HEALTHCARE AND OTHER BENEFITS

* TIMBER PHARMACEUTICALS- PHASE 3 ASCEND STUDY WILL PROGRESS WHEN CO PURSUES SALE OF MOST OF ITS ASSETS TO "STALKING HORSE" BIDDER AFFILIATED WITH LEO

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2387127147?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-11-29 07:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2387127147","market":"us","top_or_hot":-1,"title":"BRIEF-Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business","media":"Reuters","content":"<html><body><p>Nov 28 (Reuters) - <a href=\"https://laohu8.com/S/TMBR\">Timber Pharmaceuticals</a> Inc   :</p><p>   * TIMBER PHARMACEUTICALS RECEIVES COURT APPROVAL OF ALL “FIRST DAY” MOTIONS TO SUPPORT BUSINESS OPERATIONS &amp; DISCLOSES COMMUNICATION FROM NYSE AMERICAN</p><p>   * TIMBER PHARMACEUTICALS INC- HAS RECEIVED $3.0 MILLION OF NEW MONEY DIP FUNDING</p><p>   * TIMBER PHARMACEUTICALS INC- DIP FINANCING IS BEING PROVIDED BY LEO US HOLDING, INC., AS LENDER</p><p>   * TIMBER PHARMACEUTICALS: RECEIVED AUTHORIZATION TO CONTINUE TO PAY VENDORS IN ORDINARY COURSE FOR GOODS AND SERVICES PROVIDED ON A POST-PETITION BASIS</p><p>   * TIMBER PHARMACEUTICALS INC: RECEIVED AUTHORIZATION TO CONTINUE TO PAY EMPLOYEE WAGES, PROVIDE HEALTHCARE AND OTHER BENEFITS</p><p>   * TIMBER PHARMACEUTICALS- PHASE 3 ASCEND STUDY WILL PROGRESS WHEN CO PURSUES SALE OF MOST OF ITS ASSETS TO \"STALKING HORSE\" BIDDER AFFILIATED WITH LEO</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-29 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 28 (Reuters) - Timber Pharmaceuticals Inc   :   * TIMBER PHARMACEUTICALS RECEIVES COURT APPROVAL OF ALL “FIRST DAY” MOTIONS TO SUPPORT BUSINESS OPERATIONS & DISCLOSES COMMUNICATION FROM NYSE ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2387127147","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2387127147","pubTimestamp":1701213712,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 28  - Timber Pharmaceuticals Inc   :   * TIMBER PHARMACEUTICALS RECEIVES COURT APPROVAL OF ALL “FIRST DAY” MOTIONS TO SUPPORT BUSINESS OPERATIONS & DISCLOSES COMMUNICATION FROM NYSE AMERICAN   * TIMBER PHARMACEUTICALS INC- HAS RECEIVED $3.0 MILLION OF NEW MONEY DIP FUNDING   * TIMBER PHARMACEUTICALS INC- DIP FINANCING IS BEING PROVIDED BY LEO US HOLDING, INC., AS LENDER   * TIMBER PHARMACEUTICALS: RECEIVED AUTHORIZATION TO CONTINUE TO PAY VENDORS IN ORDINARY COURSE FOR GOODS AND SERVICES PROVIDED ON A POST-PETITION BASIS   * TIMBER PHARMACEUTICALS INC: RECEIVED AUTHORIZATION TO CONTINUE TO PAY EMPLOYEE WAGES, PROVIDE HEALTHCARE AND OTHER BENEFITS   * TIMBER PHARMACEUTICALS- PHASE 3 ASCEND STUDY WILL PROGRESS WHEN CO PURSUES SALE OF MOST OF ITS ASSETS TO \"STALKING HORSE\" BIDDER AFFILIATED WITH LEOSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药"},"translate_title":"简介——木材制药公司收到法院批准所有“第一天”的动议，以支持业务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMBR":1,"TMBRQ":1},"content_text":"Nov 28 (Reuters) - Timber Pharmaceuticals Inc   :   * TIMBER PHARMACEUTICALS RECEIVES COURT APPROVAL OF ALL “FIRST DAY” MOTIONS TO SUPPORT BUSINESS OPERATIONS & DISCLOSES COMMUNICATION FROM NYSE AMERICAN   * TIMBER PHARMACEUTICALS INC- HAS RECEIVED $3.0 MILLION OF NEW MONEY DIP FUNDING   * TIMBER PHARMACEUTICALS INC- DIP FINANCING IS BEING PROVIDED BY LEO US HOLDING, INC., AS LENDER   * TIMBER PHARMACEUTICALS: RECEIVED AUTHORIZATION TO CONTINUE TO PAY VENDORS IN ORDINARY COURSE FOR GOODS AND SERVICES PROVIDED ON A POST-PETITION BASIS   * TIMBER PHARMACEUTICALS INC: RECEIVED AUTHORIZATION TO CONTINUE TO PAY EMPLOYEE WAGES, PROVIDE HEALTHCARE AND OTHER BENEFITS   * TIMBER PHARMACEUTICALS- PHASE 3 ASCEND STUDY WILL PROGRESS WHEN CO PURSUES SALE OF MOST OF ITS ASSETS TO \"STALKING HORSE\" BIDDER AFFILIATED WITH LEOSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2387127147"}